A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

被引：0
|
作者：
Joaquín Casal Rubio
S. Vázquez
F. Vázquez
M. Amenedo
J. L. Fírvida
J. R. Mel
G. Huidobro
E. Álvarez
M. Lázaro
G. Alonso
I. Fernández
机构：
[1] Hospital do Meixoeiro,Department of Medical Oncology
[2] Complejo Hospitalario Xeral-Calde,undefined
[3] Hospital Arquitecto Marcide,undefined
[4] Centro Oncológico de Galicia,undefined
[5] Complejo Hospitalario,undefined
[6] Hospital Juan Canalejo,undefined
[7] Hospital Montecelo,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Chemotherapy; Cisplatin; Docetaxel; Gemcitabine; Non-small cell lung cancer; Phase II trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：379 / 384
页数：5
相关论文
共 50 条
  • [41] Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase II study
    Bretti, S
    Manzin, E
    Loddo, C
    Berruti, A
    Bombaci, S
    Vellani, G
    Celano, A
    ANTICANCER RESEARCH, 2002, 22 (05) : 3039 - 3043
  • [42] A Randomized Phase II Trial of Gemcitabine plus Carboplatin: Biweekly versus Standard Schedules in Patients with Advanced Non-Small Cell Lung Cancer
    Hasegawa, Yukihiro
    Miura, Dai
    Kitamura, Chiho
    Suzuki, Takaya
    Kobayashi, Kazurna
    Sato, Nobuyuki
    CHEMOTHERAPY, 2013, 59 (05) : 346 - 353
  • [43] Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer
    Novello, Silvia
    Falcone, Alfredo
    Crino, Lucio
    Rinaldi, Massimo
    Nardi, Mario
    De Marinis, Filippo
    Tonato, Maurizio
    Tibaldi, Carmelo
    Tinazzi, Angelo
    Russo, Francesca
    Grassivaro, Nicoletta
    Scagliotti, Giorgio Vittorio
    LUNG CANCER, 2009, 66 (03) : 327 - 332
  • [44] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Sujith Kalmadi
    Giles McNeill
    Mellar Davis
    David Peereboom
    David Adelstein
    Tarek Mekhail
    Medical Oncology, 2006, 23 : 507 - 513
  • [45] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Kalmadi, Sujith
    McNeill, Giles
    Davis, Mellar
    Peereboom, David
    Adelstein, David
    Mekhail, Tarek
    MEDICAL ONCOLOGY, 2006, 23 (04) : 507 - 513
  • [46] A comparative study of combination chemotherapy with docetaxel/cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
    El-Nashar, E
    LUNG CANCER, 2005, 49 : S243 - S243
  • [47] Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer
    Hillerdal, Gunnar
    Sederholm, Christer
    Andersson, Kerstin
    LUNG CANCER, 2011, 71 (02) : 178 - 181
  • [48] Gemcitabine/vinorelbine/cisplatin in patients with advanced non-small cell lung cancer
    Doweik, L
    Pohl, G
    Malayeri, R
    Krajnik, G
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 263 - 266
  • [49] A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels:: A phase II randomized trial
    Rinaldi, M
    Crinò, L
    Scagliotti, GV
    Mosconi, AM
    De Marinis, F
    Gridelli, C
    Selvaggi, G
    Della Giulia, M
    Darwish, S
    Porrozzi, S
    Novello, S
    Cipri, A
    Bartolucci, R
    Calandri, C
    Tonato, M
    ANNALS OF ONCOLOGY, 2000, 11 (10) : 1295 - 1300
  • [50] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
12345